Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
基本信息
- 批准号:10673933
- 负责人:
- 金额:$ 288.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAccelerationAction ResearchAddressAdvocateAffectAfrican AmericanAfrican American populationAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaAutopsyAwarenessBiological MarkersBiological Specimen BanksBloodBrainBrain imagingCaringClinicClinicalClinical ResearchClinical TrialsClinical Trials Support UnitCollaborationsCommunitiesComplementDNADataData ScientistDedicationsDementiaDevelopmentDiseaseDisparityEarly identificationEducationFacultyFamily CaregiverFosteringFoundationsFundingGeneticGoalsGrantHealth ProfessionalHeterogeneityImageIndividualIndividual DifferencesInstitutionInterventionLeadershipLinkMemoryOutcomeParticipantPathogenicityPersonal SatisfactionPilot ProjectsPlasmaPlayPreventionProteinsProteomicsPublic HealthPublicationsRaceRecommendationResearchResearch ActivityResearch PersonnelResearch SupportResourcesRiskRisk FactorsRoleSamplingScientistSpecial PopulationSpecimenSpinal CordTeacher Professional DevelopmentTrainingTranslatingTranslational ResearchTranslationsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVariantWorkbasebuilt environmentburden of illnesscaregivingcaregiving researchclinical practicecohortcommunity partnershipdata managementdesigndiversity and inclusioneducation researcheffective therapyempowermentethnoracialfaculty mentorhealthy agingimprovedinnovationmemory careminority engagementmultidisciplinaryneuropathologynext generationnoveloutreachprogramsrecruitresearch studyresponsesuccesssupportive environmentsymposiumtherapeutic targettraining opportunity
项目摘要
SUMMARY/ABSTRACT: OVERALL
The Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory University provides Georgia and the
region with comprehensive clinical, research, and educational programs. This application outlines our success
in building an environment that encourages and supports innovative projects with a central theme of discovery
and translation of new biomarkers and pathogenic mechanisms to enable early identification, intervention, and
ultimately prevention of AD and related disorders. Given the well documented disparities in clinical research
participation and burden of disease for AD in the African American community, the Goizueta ADRC dedicates
effort and resources to help better understand and address inter-individual differences in AD and ADRD,
ranging from ethno-racial factors to individual differences in genetic and protein variation. We benefit from
generous institutional support from Emory, one of the nation’s fastest growing research academic medical
centers, the generous Atlanta community, and a large and highly collaborative interdisciplinary team of more
than 100 faculty across Emory and local institutions. Our cores work in a concerted manner to effectively
recruit, evaluate, and engage a diverse cohort of participants who actively take part in a wide variety of
research studies. The addition of a Minority Engagement Core helps to further engage special populations,
most notably the African American community, to help the Outreach, Recruitment and Engagement Core and
Clinical Core with an ambitious goal of 50% African American participation in the UDS cohort. Our Biomarker
Core provides state-of-the-art genetic, proteomic, and brain imaging analyses, complemented by an extensive
biospecimen repository of well-characterized blood, CSF, and DNA samples, and a large bank of well-
characterized postmortem brains and spinal cords in the Neuropathology Core. These valuable resources will
continue to be distributed widely for a variety of approved studies, including research Developmental Projects
and in support of local and national collaborations. Generous institutional and philanthropic support is used to
seed a much larger base of innovative research. The ADRC educational programs reach a broad audience of
trainees, researchers, health care professionals, and the public. New to us with this application, the Research
Education Component will help formalize our longstanding dedication to the cultivation of the next generation
of scientists. With a strong commitment to diversity and inclusiveness, our program benefits from the
engagement of a large and multidisciplinary core of training faculty mentors from institutions throughout the
greater Atlanta area. Collectively, the ADRC is poised to continue to make important contributions to the
national strategy for AD treatment and prevention.
摘要/文摘:整体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALLAN I LEVEY其他文献
ALLAN I LEVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALLAN I LEVEY', 18)}}的其他基金
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
路易体痴呆皮质边缘病理生理学的新型蛋白质生物标志物
- 批准号:
10514142 - 财政年份:2022
- 资助金额:
$ 288.47万 - 项目类别:
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
路易体痴呆皮质边缘病理生理学的新型蛋白质生物标志物
- 批准号:
10704614 - 财政年份:2022
- 资助金额:
$ 288.47万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 288.47万 - 项目类别:
Standard Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
Standard Grant














{{item.name}}会员




